These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 23668096)

  • 1. The goals of FDA regulation and the challenges of meeting them.
    Tyler RS
    Health Matrix Clevel; 2013; 22(2):423-31. PubMed ID: 23668096
    [No Abstract]   [Full Text] [Related]  

  • 2. Shattuck lecture. Innovation, regulation, and the FDA.
    Hamburg MA
    N Engl J Med; 2010 Dec; 363(23):2228-32. PubMed ID: 21121835
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-79. PubMed ID: 23297449
    [No Abstract]   [Full Text] [Related]  

  • 4. Trying times at the FDA--the challenge of ensuring the safety of imported pharmaceuticals.
    Schweitzer SO
    N Engl J Med; 2008 Apr; 358(17):1773-7. PubMed ID: 18434648
    [No Abstract]   [Full Text] [Related]  

  • 5. Playing "kick the FDA"--risk-free to players but hazardous to public health.
    Wood AJ
    N Engl J Med; 2008 Apr; 358(17):1774-5. PubMed ID: 18434649
    [No Abstract]   [Full Text] [Related]  

  • 6. New FDA rule issued to reduce youth smoking rates, challenges to rule expected.
    McCollum C
    Wis Med J; 1996 Nov; 95(11):760-2. PubMed ID: 8952436
    [No Abstract]   [Full Text] [Related]  

  • 7. Supreme court ruling on FDA oversight of tobacco.
    Meier E
    Pediatr Nurs; 2000; 26(4):414. PubMed ID: 12026480
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceuticals and medical devices: FDA oversight.
    ; Berry MD
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-86. PubMed ID: 22403845
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA and congress: differing agendas?
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):116-7. PubMed ID: 20504131
    [No Abstract]   [Full Text] [Related]  

  • 10. The tobacco buyout and the FDA.
    Schroeder SA
    N Engl J Med; 2004 Sep; 351(14):1377-80. PubMed ID: 15459295
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841
    [No Abstract]   [Full Text] [Related]  

  • 12. The FDA and tobacco regulation.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2008 Sep; 359(10):1056-7. PubMed ID: 18768950
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinton and tobacco: what now?
    Simendinger A
    Natl J (Wash); 1998 Nov; 30(47-48):2786-7. PubMed ID: 10339060
    [No Abstract]   [Full Text] [Related]  

  • 14. Criminal conviction for distribution of a drug not approved by the FDA.
    Brushwood DB
    Am J Hosp Pharm; 1991 Apr; 48(4):747-9. PubMed ID: 2042679
    [No Abstract]   [Full Text] [Related]  

  • 15. Is tobacco a drug? The high court faces a crucial health question.
    Lavelle M
    US News World Rep; 1999 Dec; 127(22):36. PubMed ID: 10724809
    [No Abstract]   [Full Text] [Related]  

  • 16. A sick agency in need of a cure? Recall of a popular pain drug has focused attention on government drug regulation.
    Spake A
    US News World Rep; 2004 Dec; 137(21):32-3, 36. PubMed ID: 15636503
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA regulation of tobacco--pitfalls and possibilities.
    Brandt AM
    N Engl J Med; 2008 Jul; 359(5):445-8. PubMed ID: 18663229
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA, industry collaborate to strengthen painkiller restrictions.
    Sipkoff M
    Manag Care; 2009 Apr; 18(4):10-1. PubMed ID: 19472560
    [No Abstract]   [Full Text] [Related]  

  • 19. Tobacco, public health, and the FDA.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2009 Jul; 361(4):402-3. PubMed ID: 19546344
    [No Abstract]   [Full Text] [Related]  

  • 20. Forbidden and Permitted Statements about Medications--Loosening the Rules.
    Avorn J; Sarpatwari A; Kesselheim AS
    N Engl J Med; 2015 Sep; 373(10):967-73. PubMed ID: 26332553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.